Page last updated: 2024-09-03

dx 9065a and fidexaban

dx 9065a has been researched along with fidexaban in 2 studies

Compound Research Comparison

Studies
(dx 9065a)
Trials
(dx 9065a)
Recent Studies (post-2010)
(dx 9065a)
Studies
(fidexaban)
Trials
(fidexaban)
Recent Studies (post-2010) (fidexaban)
92782112

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abendschein, DR; Baum, PK; Eisenberg, PR; Light, DR; Martin, DJ; Post, J; Rumennik, G; Sullivan, ME; Vergona, R1
Doggrell, SA1

Reviews

1 review(s) available for dx 9065a and fidexaban

ArticleYear
Is there evidence to support the use of direct Factor Xa inhibitors in coronary artery disease?
    Reviews on recent clinical trials, 2011, Volume: 6, Issue:2

    Topics: Amidines; Coronary Artery Disease; Cyclic N-Oxides; Factor Xa; Factor Xa Inhibitors; Humans; Morpholines; Naphthalenes; Propionates; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiophenes

2011

Other Studies

1 other study(ies) available for dx 9065a and fidexaban

ArticleYear
Effects of ZK-807834, a novel inhibitor of factor Xa, on arterial and venous thrombosis in rabbits.
    Journal of cardiovascular pharmacology, 2000, Volume: 35, Issue:5

    Topics: Amidines; Animals; Anticoagulants; Antithrombin III; Arthropod Proteins; Coronary Thrombosis; Disease Models, Animal; Female; Intercellular Signaling Peptides and Proteins; Male; Naphthalenes; Peptides; Propionates; Pyridines; Rabbits; Species Specificity; Venous Thrombosis

2000